Delta 9 Cannabis, a Manitoba-based medical marijuana producer, has entered into a deal with a U.S. company for the rights to a technology that allows medicine to be administered through the skin or mucous membrane.

This nano technology was produced by the startup Nanosphere Health Sciences. It allows for medicines to go directly into the bloodstream, which stops it from going through the gut or the liver.

According to a news release from Delta 9, in terms of cannabis this means someone “can get better ‘bio-availability’ of cannabinoids than even smoking provides.” The company adds that it is the first technology that provides a dosage system for cannabis that is medically appropriate.

Toronto researchers have determined what dosage of a specially formulated cannabis oil is safe and can be tolerated by children with Dravet syndrome, a rare genetic form of epilepsy that causes lifelong seizures.

Researchers at the Hospital for Sick Children tested the cannabis oil, which contains CBD (cannabidiol) and a small amount of marijuana’s psychoactive ingredient THC (tetrahydrocannabidiol) in 20 children with Dravet syndrome, whose seizures were not well-controlled with standard anti-convulsant medications.

High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it has recently entered into multiple non-binding memorandums of understanding ("MOUs") to supply the Saskatchewan market on a wholesale basis for a combined total of up to 9,500 kilograms of cannabis products over the next year, as available.  High Tide is in the process of becoming a licensed wholesaler of cannabis products in the province of Saskatchewan.  The MOUs are with FV Pharma Inc. ("FV Pharma"), Maple Leaf Green World Inc. ("Maple Leaf"), Sundial Growers Inc. ("Sundial") and The Supreme Cannabis Company, Inc. ("Supreme").

The Crypto Report

IBM (NYSE:IBM) has teamed up with foreign-exchange settlement provider CLS to launch a blockchain app store for financial services, as per a Reuters report.

Hydroponics, robotics, high-powered lights — growing weed on an industrial level is a serious business. But according to one local independent grower, getting cannabis to flower is as simple as tending to a house plant.

Tom Neumann, who has a medical licence to grow and consume on his farm in Ardrossan east of Edmonton, thinks anyone who is curious should give growing a shot when it becomes legal on Oct. 17. Each household is permitted to grow four plants.

“It’s no different than growing any other plant,” Neumann said. “My parents managed apartments when I was a kid, and my brother used to grow (marijuana plants) in the hallway.”

A growing number of Canadian tech entrepreneurs are betting big on the future of cannabis in the lead up to legalization later this year. These “weed tech,” or “canna tech,” companies, as they are sometimes called, are hoping to cash in on the new legal market by creating specialized software and hardware to serve the cannabis industry and consumers.

Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") (TSX: LEAF) today announced the closing of the previously announced arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio").

Upon closing of the transaction, Aurora will submit applications with the Toronto Stock Exchange (the "TSX") and the Ontario Securities Commission (the "OSC") to delist MedReleaf's existing common shares and for MedReleaf to cease to be a reporting issuer, respectively.

Not everyone's a fan of 'blockchain' encryption, but the cannabis industry is eyeing it for protection.

The technology that powers bitcoin could be deployed to track the flow of legal product in Canada's marijuana market without compromising the privacy of its customers.

The Cannabis Act authorizes Health Canada to implement a national tracking system for marijuana — following the journey from seed to sale — to protect the integrity of the legal market.

The challenge is to keep that information confidential in an age of widespread hacking.

Heading into the third quarter of 2018, Canadian advisors are most bullish on marijuana stocks, reveals the latest advisor sentiment survey from Horizons ETFs.

The marijuana sector, as represented by the North American Marijuana Index, has the highest level of bullish sentiment in the survey, with 58% of advisors expecting marijuana stocks to deliver positive returns in Q3.

The index was up 5.78% from last quarter, with much of that performance coming from the announcement that recreational marijuana will become legal in Canada on Oct. 17.

“Since this sector is such a news-driven space, many advisors may be expecting the sector to get a big bump in interest as we near the big day,” says Steve Hawkins, president and co-CEO of Horizons ETFs, in a release.